1887

Abstract

Melioidosis is caused by the Gram-negative bacterium , whose portals of entry into the body include subcutaneous, ingestion and inhalation routes. Animal models play an important role in furthering our understanding of this disease, which is associated with high morbidity and mortality in susceptible subjects. Previous studies using intranasal inoculation showed a differential susceptibility to inhalational melioidosis in BALB/c and C57Bl/6 mice and attributed the difference to genetic factors and host response. However, a recent study found no difference in susceptibility when the two species of mice were exposed to nebulized bacteria. We sought to address this discrepancy by using a nasal route only, instead of whole-body aerosol exposure system. Employing three different clinical strains of and following the progression of disease development in both BALB/c and C57Bl/6 mice, we found that BALB/c mice were at least 10- to 100-fold more susceptible to infection than C57Bl/6 mice. Comparison of bacterial burdens in aerosol-challenged mice, at both the pulmonary and distant sites of infection, suggests that C57Bl/6 mice were more efficient in clearing the bacteria than BALB/c mice. In addition, a comprehensive study of a wide panel of chemokines and cytokines at the protein level demonstrated that hyperproduction of proinflammatory cytokines in aerosol-challenged BALB/c mice did not translate into better protection and survival of these mice, whereas a moderate increase in these proteins in aerosol-challenged C57Bl/6 mice was more beneficial in clearing the infection. This suggests that high levels of proinflammatory cytokines are detrimental and contribute to the immunopathogenesis of the infection.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47596-0
2008-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/4/508.html?itemId=/content/journal/jmm/10.1099/jmm.0.47596-0&mimeType=html&fmt=ahah

References

  1. Ashdown L. R. 1979; An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 11:293–297 [CrossRef]
    [Google Scholar]
  2. Barnes J. L., Ketheesan N. 2005; Route of infection in melioidosis. Emerg Infect Dis 11:638–639 [CrossRef]
    [Google Scholar]
  3. Barnes J. L., Ulett G. C., Ketheesan N., Clair T., Summers P. M., Hirst R. G. 2001; Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection. Immunol Cell Biol 79:490–501 [CrossRef]
    [Google Scholar]
  4. Brown A. E., Dance D. A., Suputtamongkol Y., Chaowagul W., Kongchareon S., Webster H. K., White N. J. 1991; Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein. J Infect Dis 163:1145–1148 [CrossRef]
    [Google Scholar]
  5. Car B. D., Eng V. M., Schnyder B., Ozmen L., Huang S., Gallay P., Heumann D., Aguet M., Ryffel B. 1994; Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 179:1437–1444 [CrossRef]
    [Google Scholar]
  6. Cheng A. C., Currie B. J. 2005; Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18:383–416 [CrossRef]
    [Google Scholar]
  7. Cheng A. C., Jacups S. P., Gal D., Mayo M., Currie B. J. 2006; Extreme weather events and environmental contamination are associated with case-clusters of melioidosis in the Northern Territory of Australia. Int J Epidemiol 35:323–329
    [Google Scholar]
  8. Currie B. J. 2003; Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 22:542–550 [CrossRef]
    [Google Scholar]
  9. Currie B. J., Jacups S. P. 2003; Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 9:1538–1542 [CrossRef]
    [Google Scholar]
  10. Easton A., Haque A., Chu K., Lukaszewski R., Bancroft G. J. 2007; A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei . J Infect Dis 195:99–107 [CrossRef]
    [Google Scholar]
  11. Friedland J. S., Suputtamongkol Y., Remick D. G., Chaowagul W., Strieter R. M., Kunkel S. L., White N. J., Griffin G. E. 1992; Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 60:2402–2408
    [Google Scholar]
  12. Gan Y. H. 2005; Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy?. J Infect Dis 192:1845–1850 [CrossRef]
    [Google Scholar]
  13. Guyton A. C. 1947; Measurement of the respiratory volumes of laboratory animals. Am J Phys 150:70–77
    [Google Scholar]
  14. Heremans H., Van Damme J., Dillen C., Dijkmans R., Billiau A. 1990; Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med 171:1853–1869 [CrossRef]
    [Google Scholar]
  15. Hoppe I., Brenneke B., Rohde M., Kreft A., Haussler S., Reganzerowski A., Steinmetz I. 1999; Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun 67:2891–2900
    [Google Scholar]
  16. Howe C., Sampath A., Spotnitz M. 1971; The pseudomallei group: a review. J Infect Dis 124:598–606 [CrossRef]
    [Google Scholar]
  17. Jeddeloh J. A., Fritz D. L., Waag D. M., Hartings J. M., Andrews G. P. 2003; Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 71:584–587 [CrossRef]
    [Google Scholar]
  18. Koo G. C., Gan Y. H. 2006; The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection. BMC Immunol 7:19 [CrossRef]
    [Google Scholar]
  19. Lauw F. N., Simpson A. J., Prins J. M., Smith M. D., Kurimoto M., van Deventer S. J., Speelman P., Chaowagul W., White N. J., van der Poll T. 1999; Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis 180:1878–1885 [CrossRef]
    [Google Scholar]
  20. Leakey A. K., Ulett G. C., Hirst R. G. 1998; BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog 24:269–275 [CrossRef]
    [Google Scholar]
  21. Lertmemongkolchai G., Cai G., Hunter C. A., Bancroft G. J. 2001; Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol 166:1097–1105 [CrossRef]
    [Google Scholar]
  22. Liu B., Koo G. C., Yap E. H., Chua K. L., Gan Y. H. 2002; Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 70:504–511 [CrossRef]
    [Google Scholar]
  23. Liu Y., Loh J. P., Aw L. T., Yap E. P., Lee M. A., Ooi E. E. 2006; Rapid molecular typing of Burkholderia pseudomallei , isolated in an outbreak of melioidosis in Singapore in 2004, based on variable-number tandem repeats. Trans R Soc Trop Med Hyg 100:687–692 [CrossRef]
    [Google Scholar]
  24. Reed L. J., Muench H. A. 1938; Simple method of estimating fifty per cent endpoints. Am J Hyg 27:493–497
    [Google Scholar]
  25. Santanirand P., Harley V. S., Dance D. A., Drasar B. S., Bancroft G. J. 1999; Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei . Infect Immun 67:3593–3600
    [Google Scholar]
  26. Ulett G. C., Ketheesan N., Hirst R. G. 2000; Proinflammatory cytokine mRNA responses in experimental Burkholderia pseudomallei infection in mice. Acta Trop 74:229–234 [CrossRef]
    [Google Scholar]
  27. Wiersinga W. J., van der Poll T., White N. J., Day N. P., Peacock S. J. 2006; Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei . Nat Rev Microbiol 4:272–282 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47596-0
Loading
/content/journal/jmm/10.1099/jmm.0.47596-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error